GSA Capital Partners’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$795K Buy
+22,135
New +$573K 0.05% 601
2024
Q2
Sell
-33,204
Closed -$493K 1671
2024
Q1
$493K Buy
+33,204
New +$529K 0.04% 889
2023
Q4
Sell
-10,280
Closed -$196K 1543
2023
Q3
$196K Sell
10,280
-7,230
-41% -$125K 0.02% 1290
2023
Q2
$278K Buy
+17,510
New +$288K 0.03% 1089
2023
Q1
Sell
-14,540
Closed -$245K 1534
2022
Q4
$245K Sell
14,540
-3,454
-19% -$55.7K 0.03% 1064
2022
Q3
$231K Buy
+17,994
New +$258K 0.03% 1120
2020
Q3
Sell
-22,362
Closed -$51K 1256
2020
Q2
$51K Buy
+22,362
New +$47.8K 0.03% 537
2019
Q4
Sell
-100,917
Closed -$367K 1463
2019
Q3
$367K Sell
100,917
-14,694
-13% -$62.8K 0.05% 753
2019
Q2
$484K Buy
115,611
+22,793
+25% +$91.2K 0.05% 681
2019
Q1
$330K Buy
92,818
+56,130
+153% +$187K 0.03% 941
2018
Q4
$81K Sell
36,688
-166,205
-82% -$686K 0.01% 1238
2018
Q3
$1.3M Sell
202,893
-72,319
-26% -$513K 0.07% 501
2018
Q2
$2.05M Buy
275,212
+16,656
+6% +$125K 0.1% 264
2018
Q1
$1.82M Sell
258,556
-86,278
-25% -$638K 0.1% 330
2017
Q4
$2.65M Sell
344,834
-16,502
-5% -$138K 0.16% 117
2017
Q3
$3.02M Buy
361,336
+130,514
+57% +$813K 0.21% 47
2017
Q2
$981K Buy
230,822
+96,622
+72% +$388K 0.06% 558
2017
Q1
$510K Sell
134,200
-3,700
-3% -$14.6K 0.03% 1081
2016
Q4
$552K Buy
137,900
+108,800
+374% +$444K 0.03% 926
2016
Q3
$131K Sell
29,100
-10,200
-26% -$52.5K 0.01% 1668
2016
Q2
$193K Sell
39,300
-58,263
-60% -$330K 0.01% 1580
2016
Q1
$1.15M Buy
97,563
+69,842
+252% +$971K 0.07% 462
2015
Q4
$552K Buy
+27,721
New +$685K 0.03% 1102
2015
Q3
Sell
-36,508
Closed -$929K 1774
2015
Q2
$929K Buy
36,508
+11,800
+48% +$313K 0.04% 963
2015
Q1
$594K Buy
+24,708
New +$625K 0.02% 1260
2014
Q1
Sell
-11,416
Closed -$297K 1583
2013
Q4
$297K Buy
11,416
+2,554
+29% +$71.4K 0.02% 1206
2013
Q3
$242K Buy
+8,862
New +$278K 0.02% 1280

Other funds holding CLMT

GSA Capital Partners's CLMT Position: Q1 2026 in Review

GSA Capital Partners opened a new position in Calumet Specialty Products (CLMT) in Q1 2026: 22,135 shares worth $795K. The stake represents 0.05% of the portfolio and ranks #601 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in CLMT as recently as Q1 2024.

GSA Capital Partners first reported a position in CLMT in Q3 2013 and has held it in 27 quarters since. The position peaked at $3.02M in Q3 2017. 180 funds tracked by Wall St. Rank hold CLMT as of Q1 2026.

  • GSA Capital Partners held 22,135 shares of Calumet Specialty Products worth $795K as of Q1 2026.
  • Calumet Specialty Products was a new GSA Capital Partners position in Q1 2026.
  • Calumet Specialty Products made up 0.05% of GSA Capital Partners's portfolio in Q1 2026, its #601 holding.
  • GSA Capital Partners first reported a position in Calumet Specialty Products in Q3 2013 and has held it in 27 quarters since.
  • GSA Capital Partners's Calumet Specialty Products position peaked at $3.02M in Q3 2017.
  • 180 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.